We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Anti-anxiety medication limits empathetic behavior in rats

Study confirms previous research showing that rats display empathy when freeing trapped companions.
News

Researchers look into the brains of music fans

Study shows which brain areas are active, when we can decide about music prices ourselves.
News

Production of a molecule for memory of salt concentration

Insulin receptor in a single neuron directs behavior of worms.
News

“Amazing Protein Diversity” Discovered in Maize

The genome of the corn plant – or maize, as it’s called almost everywhere except the US – “is a lot more exciting” than scientists have previously believed. So says the lead scientist in a new effort to analyze and annotate the depth of the plant’s genetic resources.
News

Fix for 3-Billion-Year-Old Genetic Error

Researchers at The University of Texas at Austin have developed a fix that allows RNA to accurately proofread for the first time.
News

Oxford Immunotec to Acquire Imugen

Oxford Immunotec has announced it has entered into a definitive agreement to acquire substantially all of the assets of Imugen, Inc. for $22.2 million in an all cash transaction expected to close on July 1, 2016.
News

How Cancer Spreads in the Body

Cancer cells appear to depend on an unusual survival mechanism to spread around the body, according to an early study led by Queen Mary University of London.
News

BioDuro Launches as Unique CDMO

A CRO to meet market demand for better and accelerated drug discovery and development to improve efficiency in establishing drug candidate success.
News

EpimAb, Innovent Announce Collaboration

Company has announced collaboration with Innovent Biologics for the development of bispecific antibodies.
News

Savolitinib Global Phase II Trial Initiated in EGFR

Company has announced the initiation of a Phase II expansion of the ongoing TATTON trial to evaluate the selective c-Met inhibitor savolitinib in EGFR mutant NSCLC.
Advertisement